Introduction. Point-of-care testing of fetal scalp blood lactate is used as an alternative to pH analysis in fetal scalp blood sampling (FBS) during labor. Lactate measurements are not standardized and values vary with each device used. The aim of this study was to evaluate StatStrip â Lactate (SSL) in the
Introduction
Fetal scalp blood sampling (FBS) is used in addition to a non-reassuring intrapartum cardiotocogram (CTG) to assess fetal acidosis. FBS with pH analysis has been considered the gold standard but has some major drawbacks; a relatively large amount of blood is needed (35-100 lL) and the logistics of sampling and analysis are time-consuming (15-30 min) with high failure rates (11-20%) (1,2). Moreover, handling of the sample, aerobic contamination and processing affect pH results. Lactate measurement in FBS is an attractive alternative. Persistent hypoxia/ischemia leads to lactate accumulation and metabolic acidosis, which is the most important indicator of subsequent neonatal morbidity (3, 4) . Several studies, including randomized controlled trials, have shown that scalp blood lactate has similar or better predictive properties in identifying short-term neonatal morbidity compared with fetal pH, without affecting the rate of metabolic acidosis at birth or operative deliveries for suspected fetal distress (5-7). Point-of-care testing (POCT) for lactate has several advantages. It requires a tiny amount of blood (0.7-5.0 lL) and results are rapidly available (13-60 s) at a low failure rate (1-3%) (2, 8, 9) . However, POCT lactate measurements are not standardized and values vary with the device used and the type of blood compartment sampled (i.e. plasma, hemolysed blood or whole blood with intact erythrocytes). Therefore, the test characteristics and cut-off values in fetal scalp blood have to be established for each device. In a previous study we compared the characteristics of two POCT lactate devices, Lactate Pro â (Akray, Kyoto, Japan) and StatStrip â Lactate (SSL), in a laboratory setting, using the RapidLab blood gas analyzer as a reference method. Compared with the Lactate Pro â , SSL showed a closer correlation with the reference method, better test characteristics, and a smaller coefficient of variation (10) . The value of SSL for its use in the clinical setting remained to be evaluated.
The aim of this study was to investigate SSL for its use in FBS in a clinical setting. For this purpose, we assessed the agreement of SSL, lactate (RLL) and pH (RLpH) measured on the RapidLab blood gas analyzer. We also assessed the discrepancy rates between the methods using the previously established SSL cut-off values that served as indicators for both reassurance and immediate delivery.
Material and methods
We conducted a prospective observational study with SSL in FBS obtained from women with suspected fetal distress during labor. The study was performed at the Radboud University Medical Center between 13 February 2010 and 12 March 2011. Included were women with a singleton fetus in vertex presentation and a gestational age of 34 weeks or over. The study was approved by the University Ethics Committee (2009/345).
The Radboud University Medical Center is a tertiary referral center with approximately 1500 deliveries per year (low, medium and high-risk). Deliveries are managed by midwives and residents supervised by obstetricians. CTGs are classified and interpreted according to the guidelines of the International Federation of Gynecology and Obstetrics (11) . FBS is performed in the case of an intermediary or abnormal CTG trace, as interpreted by the obstetric caregiver. FBS is performed in approximately 11% of deliveries (12) .
FBS was carried out using a standard technique (13 6 mmol/L) from a retrospective cohort into the formula: SSL = 1.13*RL -0.39, which was generated from a comparison study of RL and SSL in 38 FBS samples (10, 12) . The discrepancy rates were studied using crosstabulation. Neonatal acid-base status was evaluated systematically through umbilical cord blood gas analysis from both artery and vein immediately after birth. For the purpose of this study only data from the umbilical artery were used in the analysis, assuming it to reflect fetal condition best. Severe metabolic acidosis at birth was defined as pH <7.05 and BD >12.0 mmol/L in umbilical artery blood (7) .
Statistical analysis was performed with SPSS version 22 (IBM SPSS Inc., Armonk, NY, USA). Relations between SSL, RLL and RLpH in FBS were tested using regression analysis. We constructed a Bland-Altman graph to assess the variability between the measurements across the range of values for SSL and RLL. Data are presented as medians with 95 (2.5-97.5) centile ranges.
Results
During the study period 1589 women delivered at the RUMC. FBS was performed in 139 (9%) women. The intrapartum characteristics of these mother-baby pairs are summarized in Table 1 . There were no complications of the FBS procedure. There was a wide variance in the sampling to delivery interval, ranging from a few minutes to several hours. In 112 (35%) cases FBS was performed at full dilation. Three percent of infants in the studied population had metabolic acidosis at birth.
From the 139 women, 323 fetal scalp blood samples were obtained in which RLL and RLpH were measured ( Figure 1 ). Parallel measurement of SSL was performed in 247 of these samples. SSL, RLL and RLpH analysis failed in 7% (17/247), 23% (73/323) and 43% (140/323), respectively. For further analysis, one sample was excluded due to a 30-min interval between SSL and RLL/ RLpH measurement.
In 142 fetal scalp blood samples, both SSL and RLL results were available. We found a strong agreement (R 2 = 0.747), as shown in Figure 2 . In 82% (117/142) of the samples, SSL (≤5.7 mmol/L) correctly indicated the absence of lactemia (RLL ≤5.4 mmol/L). There was a discrepancy between SSL and RLL for these cut-off values in 6% (9/142) of the samples. In 5% (7/142) of the samples, SSL (≥7.0 mmol/L) correctly indicated the presence of lactemia (RLL ≥6.6 mmol/L). There was a discrepancy between SSL and RLL for these cut-off values in 2% (3/ 142) of the samples. A Bland-Altman graph analysis showed minimal variance between SSL and RLL, and a slight linear increase with increasing lactate concentrations, i.e. SSL measured slightly higher than RLL with increasing lactate values ( Figure 3) .
In 191 fetal scalp blood samples, both SSL and RLpH results were available. Fetal scalp SSL values correlated poorly with scalp RLpH (Figure 4 ; R 2 = 0.206). In 77% (148/191) of the samples, SSL (≤5.7 mmol/L) correctly indicated the absence of acidemia (RLpH ≥7.25). There was a discrepancy between SSL and RLpH for these cutoff values in 14% (27/191) of the samples. In these discrepant samples, 15 cases showed normal SSL values, whereas pH did not. In these cases, all but one RLpH value (7.08) indicated pre-acidemia (7.20-7.25 ). Twelve cases showed normal RLpH values, whereas SSL did not. Of these, SSL levels indicated pre-acidemia (5.7-7.0 mmol/L) and acidemia (≥7.0 mmol/L) in nine and three cases, respectively.
In 3% (6/191), SSL (≥7.0 mmol/L) correctly indicated the presence of acidemia (RLpH ≤7.20). There was a discrepancy between SSL and RLpH for these cut-off values in 5% (10/191) of the samples. These discrepant samples are presented in more detail in Table 2 . Five cases showed SSL values indicating acidemia, whereas RLpH did not. In these cases, RLpH values were within the normal to pre-acidemic range. None of these infants had metabolic acidosis at birth. In the five cases where RLpH indicated acidemia and SSL did not, SSL levels were all in the pre-acidemic range (5.7-7.0 mmol/L) except for Case 9. In this child, a scalp blood sample was taken within 26 min of birth. There was a large discrepancy between SSL (3.8 mmol/L) and RLpH (7.08) in this FBS sample. Further investigation of this case showed that a ventouse delivery was performed because of persistent bradycardia. In all cases, SSL values were in line with the available RLL values, suggesting a correct lactate measurement rather than a false negative result in relation to RLpH.
In 182 fetal scalp blood samples, both RLL and RLpH results were available. Fetal scalp RLL values correlated poorly with scalp RLpH (R 2 = 0.110). We observed discrepancies between RLL (≤5.4 mmol/L) and RLpH (≥7.25) in 17% (31/182) of the samples. For cut-off values for RLL (≥6.6 mmol/L) and and RLpH (≤7.20) there was 7% (12/182) discrepancy. These numbers were comparable to the ones we observed between SSL and RLpH.
Discussion
In this study we tested the value of SSL for its use in FBS in a clinical setting. We found that the lactate level in fetal scalp blood is accurately measured by SSL at a much lower failure rate compared with RLpH and RLL. In the vast majority of cases, SSL cut-off values provided correct information on fetal status.
Previous studies that have validated SSL showed reliable results (10, 19, 20) . However, these studies only used cord blood or a small number of fetal scalp samples, and therefore do not adequately represent real labor ward conditions. To our best knowledge this is the first study that has evaluated a POCT lactate device in a clinical setting with a large number of scalp blood samples. We found a strong agreement of SSL with RLL. This suggests that SSL is suitable for POCT lactate analysis in FBS.
Measurement of SSL has a lower failure rate than RLpH/RLL. We detected an SSL failure rate of 7%. This is fairly high compared with the literature (1-3%) (2, 6, 8) . This might be due to the fact that our labor ward staff was not yet familiar with the device and that samples were not immediately repeated after failure. Recent experience with SSL on our ward shows that the failure rate can be reduced to nil by quick analysis of a second drop. The failure rates for RLpH and RLL analysis in our study were 23% and 43%, respectively, which is in line with other studies (10-20% for pH only and >50% for simultaneous pH/lactate analysis) (2). The required sample volume and the way the blood gas analyzer handles the sample can explain this large difference in failure rates between SSL and RLL/RLpH. Standard blood gas analyzers, including the RapidLab 860, require a large volume of 50-100 lL for determining pH and lactate results. If the sampling volume is too small, at best only pH is measured. SSL has the convenience of a very low sampling volume (0.7 lL), making it an attractive tool in the obstetric setting.
FBS with pH and/or lactate analysis can be used to discriminate the fetus that tolerates labor well from the fetus with a developing acidemia in the case of a non-reassuring CTG. As presented in other studies, we found that the correlation between SSL and pH in fetal scalp blood is poor and that discrepancies are quite common (14) . As both parameters might reflect different aspects of a developing acidemia, one may question whether discrepancies should be considered false positive or false negative test results, or pH is not the correct gold standard. A low pH with a normal lactate can be due to transient impairment of the carbon dioxide exchange following umbilical cord compression or an early stage of a fast developing acidosis. A normal pH with a high lactate can be explained by: (1) slow clearance of lactate from the fetal circulation and fast normalization of pH some time after an hypoxic insult; (2) an early stage of a slowly developing acidosis; (3) factors other than hypoxia, such as contamination of amniotic fluid or limited local perfusion as occurs with caput formation (8, 12, 15, 16) . Furthermore, the fetal acidbase balance is influenced by the administration of betamimetic drugs, glucose, maternal hyperventilation and catecholamine concentrations (17, 18) . It might therefore be wise to perform parallel analyses of both pH and lactate in FBS, as they might mirror different stages of a developing asphyxia.
Concern has been raised that combined sampling (pH and lactate) might increase the rate of operative delivery for fetal distress, due to an increased rate of abnormal results compared with single tests. Liljestrom et al. showed that combined sampling results in a 66% operative delivery rate vs. 95% if single testing is used (pH or lactate) (7, 14) . One may argue that the use of a test with a 20% failure rate is not justified. We identified 5 and 14% discrepancies between SSL and RLpH for the cut-off values for reassuring fetal status and immediate intervention, respectively. Because of these discrepancies and the lack of a randomized controlled trial comparing combined testing with single testing, we propose combined sampling to reduce the chance of missing fetal hypoxia. To avoid repeated sampling when pH analysis fails, clinical management in those cases is based on SSL only. A summary of the clinical guideline we have implemented in our labor ward is provided in Table 3 .
The goal of FBS is to prevent adverse neonatal outcome. The commonly accepted thresholds for scalp pH are ≤7.20 and ≥7.25 for immediate delivery, and reassuring fetal status. In a population of 486 fetuses in whom FBS was performed, we found that these values correspond to the 15th and 25th percentile, respectively (12) . established by Ridenour et al. (20) . They compared Lactate Pro â and Lactate Plus â (an earlier version of SSL) with a lactate reference method using neonatal cord blood. Based on both regression and ROC curve analysis they found that cut-offs predicted scalp pH of <7.20 at 7.0 and 6.8 mmol/L, respectively. They concluded that sensitivity and specificity of Lactate Pro â and Lactate Plus â for predicting acidosis is nearly identical, suggesting that there is no difference in the ability of the devices to predict acidosis, although that different cutoffs for this purpose must be used. As expected and in line with Ridenour et al. (20) , there was poor agreement between SSL and RLpH. We found strong agreement and a low discrepancy rate between the POCT device (SSL) and the reference method (RLL). To our knowledge this comparison has never been made in a clinical setting. Although the cut-off values for SSL need to be tested prospectively in clinical outcome studies, the above suggests that the thresholds defined for SSL seem to be adequate. Several limitations can be identified in our study. First, in 76 samples, SSL analysis was not performed at all. This was probably due to the fact that our labor ward staff was not yet familiar with the device. Secondly, we were not able to relate the threshold values to neonatal outcome, as the time interval between FBS and delivery varied from 10 min to eight hours. Our study design did not allow for such analysis as we did not use the SSL values for clinical management. This provides scope for future research. Thirdly, our population contained only a few samples representing fetal acidosis. However, the low prevalence of poor outcome is a common problem in evaluating tests for fetal well-being during labor. FBS is an important tool to exclude acidosis when the CTG is abnormal, as the intrapartum CTG has a high false positive rate for this outcome.
In conclusion we showed that SSL is a reliable test and can be used in daily obstetric practice for POCT lactate testing in fetal scalp blood. SSL provides accurate information on fetal status in the vast majority of cases at a minimal failure rate. As there are discrepancies between SSL and RLpH and the cut-off values have not yet been evaluated prospectively regarding intervention rates and neonatal outcome, we propose combined testing of SSL and pH in FBS. In the borderline group, repeated sampling over 20-30 min is recommended. In the case of discrepancies (pH normal, SSL borderline/ abnormal or vice versa), seek senior consultancy; repeated sampling or delivery.
